Mutations in unfolded protein response regulator ATF6 cause hearing and vision loss syndrome
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci175562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Eun-Jin Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology and. Hauptthemen laut MEDLINE: Activating Transcription Factor 6, Unfolded Protein Response, Hearing Loss, Sensorineural, Mutation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, BLRD VA, NINDS NIH HHS.
Abstract (Originalsprache)
Activating transcription factor 6 (ATF6) is a key regulator of the unfolded protein response (UPR) and is important for ER function and protein homeostasis in metazoan cells. Patients carrying loss-of-function ATF6 disease alleles develop the cone dysfunction disorder achromatopsia. The effect of loss of ATF6 function on other cell types, organs, and diseases in people remains unclear. Here, we report that progressive sensorineural hearing loss was a notable complaint in some patients carrying ATF6 disease alleles and that Atf6 –/– mice also showed progressive auditory deficits affecting both sexes. In mice with hearing deficits, we found disorganized stereocilia on hair cells and focal loss of outer hair cells. Transcriptomics analysis of Atf6 –/– cochleae revealed a marked induction of the UPR, especially through the protein kinase RNA-like endoplasmic reticulum kinase (PERK) arm. These findings identify ATF6 as an essential regulator of cochlear health and function. Furthermore, they support the idea that ATF6 inactivation in people causes progressive sensorineural hearing loss as part of a blindness-deafness genetic syndrome targeting hair cells and cone photoreceptors. Last, our genetic findings indicate that ER stress is an important pathomechanism underlying cochlear damage and hearing loss, with clinical implications for patient lifestyle modifications that minimize environmental and physiological sources of ER stress to the ear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pathology and.
- Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.
- VA Palo Alto Healthcare System, Palo Alto, California, USA.
- Rush University Medical College, Chicago, Illinois, USA.
- Departments of Otolaryngology and Neuroscience, UCSD and Veterans Administration Medical Center, La Jolla, California, USA.
Förderung
- NIA NIH HHS
- BLRD VA
- NINDS NIH HHS
- NEI NIH HHS
- VA
- NIH
- CIRM
Zitieren
APA
Lee, E. J., Kim, K., Diaz-Aguilar, M. S., Min, H., Chavez, E., Steinbergs, K. J., Safarta, L. A., Zhang, G., Ryan, A. F., & Lin, J. H. (2025). Mutations in unfolded protein response regulator ATF6 cause hearing and vision loss syndrome. Journal of Clinical Investigation. https://doi.org/10.1172/jci175562
Vancouver
Lee EJ, Kim K, Diaz-Aguilar MS, Min H, Chavez E, Steinbergs KJ, et al. Mutations in unfolded protein response regulator ATF6 cause hearing and vision loss syndrome. Journal of Clinical Investigation. 2025. doi:10.1172/jci175562
BibTeX
@article{Lee2025,
author = {Lee, Eun-Jin and Kim, Kyle and Diaz-Aguilar, Monica Sophia and Min, Hyejung and Chavez, Eduardo and Steinbergs, Korina J and Safarta, Lance A and Zhang, Guirong and Ryan, Allen F and Lin, Jonathan H},
title = {Mutations in unfolded protein response regulator ATF6 cause hearing and vision loss syndrome},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci175562}
}
EUVIMED